Product Information

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.9750 per EA under NDC 69367041601. Its NADAC has been published 22 times since Jan 28, 2026.

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE

BUTALBITAL, ASPIRIN, AND CAFFEINE
$0.9750per EA
DEA Schedule CIII

Strength

325; 50; 40 mg/1; mg/1; mg/1

NDC

69367041601

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA078149

On Market Since

10/24/2025

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Cyclooxygenase Inhibitors
Decreased Platelet Aggregation
Decreased Prostaglandin Production
Methylxanthine
Nonsteroidal Anti-inflammatory Drug
Platelet Aggregation Inhibitor
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has been published 22 times since Jan 28, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.9750 per EA
All-time high$0.9890 (Feb 11, 2026)
All-time low$0.9704 (Apr 22, 2026)
52-week high$0.9890
52-week low$0.9704
Median price$0.9792
Average price$0.9796
Largest weekly change-0.9% (Apr 22, 2026)
Weeks tracked22
Tracking sinceJan 28, 2026

Price History

1W

0.0%

1M

-0.3%

3M

-0.4%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-1.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the BUTALBITAL, ASPIRIN, AND CAFFEINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Westminster Pharmaceuticals LLC, is $0.9750 per EA (NDC 69367041601), effective Jun 24, 2026.

How has the price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 22 weekly CMS publications since Jan 28, 2026.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

Since Jan 28, 2026, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $0.9704 (Apr 22, 2026) to a high of $0.9890 (Feb 11, 2026), with a median of $0.9792 per EA.

Are there cheaper alternatives to BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, so no direct lower-cost alternative is listed.

Who manufactures BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?

BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE (NDC 69367041601) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.